Marine Microbiome as a Source of Antimalarials.

Area of Science:

• Marine microbiology
• Drug discovery
• Parasitology

Background:

• Emergence of drug-resistant Plasmodium falciparum necessitates novel antimalarial pharmacophores.
• Marine invertebrate-associated microbes are an underexplored resource for drug leads.

Purpose of the Study:

• To investigate the potential of marine microorganisms as a source of antimalarial compounds.
• To identify novel antiplasmodial agents from marine microbial metabolites.

Main Methods:

• Phenotypic screening of 2365 diverse microbial extracts against a multidrug-resistant Plasmodium falciparum strain.
• Counter-screening of active extracts against mammalian cells to assess cytotoxicity.
• Identification of potent bioactive leads based on inhibition and selectivity.

Main Results:

• 317 microbial extracts showed significant inhibition (>70% at 1 µg/mL) against the malaria parasite.
• 17 potent bioactive leads were identified from various marine microbial taxa.
• The study confirmed antiplasmodial activity in marine microbial-derived compounds.

Conclusions:

• The marine microbiome is a rich and underexplored reservoir for discovering novel antiplasmodial compounds.
• Marine microorganisms represent a viable strategy for developing new antimalarial drugs.
• Further exploration of marine microbial natural products is warranted for drug development.